Literature DB >> 1416413

Methacholine responsiveness, smoking, and atopy as risk factors for accelerated FEV1 decline in male working populations.

A J Frew1, S M Kennedy, M Chan-Yeung.   

Abstract

Longitudinal lung function data from four occupational health surveys was used to explore the relationship between nonspecific bronchial responsiveness (NSBR) and the rate of decline of FEV1 (RDFEV) and to address other factors that may predict or influence RDFEV. Of the 1,203 subjects with baseline methacholine and lung function data, follow-up data were available for 733 individuals (61%). The data-available and data-unavailable groups were well matched with respect to baseline lung function, atopy, and smoking status. Compared with the unavailable group, those available for follow-up were younger (42.5 versus 37.7 yr; p less than 0.0001) and slightly less responsive to methacholine (p less than 0.01). Somewhat unexpectedly, RDFEV was lower in the 30 asthmatic subjects than in the nonasthmatics. Among the nonasthmatic subgroup (96% of those available for follow-up), age, occupational group, and baseline FEV1 (% predicted) were independent predictive factors for RDFEV. When these factors were included in the model, RDFEV was found to be increased among current smokers compared with never-smokers or ex-smokers. In the final regression model, a relationship was found between methacholine sensitivity (calculated as a dose-response slope) and RDFEV in nonasthmatics (p less than 0.05). Stratification by smoking status revealed that the relationship between RDFEV and bronchial responsiveness was confined to current smokers and that atopy was an additional risk factor in this subgroup only. This relationship was valid among current smokers in each of the three occupational groups studies. However, reinclusion of the 30 asthmatic subjects in the study population obscured the relationship between NSBR and RDFEV.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416413     DOI: 10.1164/ajrccm/146.4.878

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Longitudinal decline in lung function in patients with occupational asthma due to western red cedar.

Authors:  F J Lin; H Dimich-Ward; M Chan-Yeung
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

Review 2.  Reproducibility of non-specific bronchial challenge in adults: implications for design, analysis and interpretation of clinical and epidemiological studies.

Authors:  S Chinn; J P Schouten
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

3.  Cough threshold in patients with chronic obstructive pulmonary disease.

Authors:  C H Wong; A H Morice
Journal:  Thorax       Date:  1999-01       Impact factor: 9.139

4.  Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  Daniel B Jamieson; Elizabeth C Matsui; Andrew Belli; Meredith C McCormack; Eric Peng; Simon Pierre-Louis; Jean Curtin-Brosnan; Patrick N Breysse; Gregory B Diette; Nadia N Hansel
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

Review 5.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

6.  Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study.

Authors:  Donatella Talini; Federica Novelli; Elena Bacci; Marialaura Bartoli; Silvana Cianchetti; Francesco Costa; Federico L Dente; Antonella Di Franco; Manuela Latorre; Laura Malagrinò; Barbara Vagaggini; Alessandro Celi; Pierluigi Paggiaro
Journal:  BMJ Open       Date:  2015-01-05       Impact factor: 2.692

7.  The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function.

Authors:  Jianmin Jin; Xiaofang Liu; Yongchang Sun
Journal:  Respir Res       Date:  2014-10-29

8.  Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.

Authors:  Michael J Abramson; Sonia Kaushik; Geza P Benke; Brigitte M Borg; Catherine L Smith; Shyamali C Dharmage; Bruce R Thompson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-26

9.  Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.

Authors:  Chun-Yu Lo; Hung-Yu Huang; Jung-Ru He; Tzu-Ting Huang; Chih-Chen Heh; Te-Fang Sheng; Kian Fan Chung; Han-Pin Kuo; Chun-Hua Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.